VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_14-vv-01111 Package ID: USCOURTS-cofc-1_14-vv-01111 Petitioner: Eula Jane Matthews Filed: 2015-11-30 Decided: 2015-11-30 Vaccine: influenza Vaccination date: 2011-11-18 Condition: Guillain-Barré Syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) Outcome: compensated Award amount USD: 150000 AI-assisted case summary: Eula Jane Matthews filed a petition on November 30, 2015, alleging that an influenza vaccine administered on November 18, 2011, caused her to develop Guillain-Barré Syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP). The respondent, the Secretary of Health and Human Services, denied that the flu vaccine caused petitioner's alleged injuries. The parties reached a settlement agreement to resolve the case. Special Master Laura D. Millman reviewed the stipulation and found its terms to be reasonable. The court adopted the stipulation and awarded Eula Jane Matthews $150,000.00 as compensation for all damages. The award was to be paid as a lump sum check. The decision was issued on November 30, 2015. The public decision does not describe the onset of symptoms, specific clinical details, diagnostic tests, treatments, or expert witnesses. Gil L. Daley, II, represented the petitioner, and Althea W. Davis represented the respondent. Theory of causation field: Petitioner Eula Jane Matthews alleged that her November 18, 2011, influenza vaccine caused Guillain-Barré Syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP). The respondent denied causation. The parties reached a stipulation to settle the case, and Special Master Laura D. Millman adopted the stipulation, awarding $150,000.00 in damages. The public decision does not detail the specific theory of causation, mechanism, or any expert testimony presented. The case was settled via stipulation, with the award issued on November 30, 2015. Petitioner counsel was Gil L. Daley, II, and respondent counsel was Althea W. Davis. Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_14-vv-01111-0 Date issued/filed: 2015-12-21 Pages: 7 Docket text: PUBLIC DECISION (Originally filed: 11/30/2015) regarding 28 DECISION Stipulation/Proffer Signed by Special Master Laura D Millman. (tlf) Copy to parties. -------------------------------------------------------------------------------- Case 1:14-vv-01111-UNJ Document 33 Filed 12/21/15 Page 1 of 7 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 14-1111V Filed: November 30, 2015 Not for Publication ************************************* EULA JANE MATTHEWS, * * Petitioner, * Damages decision based on * stipulation; influenza (flu) vaccine; v. * Guillain-Barré Syndrome (GBS); * chronic inflammatory SECRETARY OF HEALTH * demyelinating polyneuropathy AND HUMAN SERVICES, * (CIDP) * Respondent. * * ************************************* Gil L. Daley, II, Fort Worth, TX, for petitioner. Althea W. Davis, Washington, DC, for respondent. MILLMAN, Special Master DECISION AWARDING DAMAGES1 On November 30, 2015, the parties filed the attached stipulation in which they agreed to settle this case and described the settlement terms. Petitioner alleges that she suffered Guillain- Barré Syndrome (“GBS”) and chronic inflammatory demyelinating polyneuropathy (“CIDP”) caused by her November 18, 2011 receipt of influenza (“flu”) vaccine. Respondent denies that the flu vaccine caused petitioner’s GBS, CIDP, or any other injury. Nonetheless, the parties agreed to resolve this matter informally. 1 Because this unpublished decision contains a reasoned explanation for the special master’s action in this case, the special master intends to post this unpublished decision on the United States Court of Federal Claims’s website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, 116 Stat. 2899, 2913 (Dec. 17, 2002). Vaccine Rule 18(b) states that all decisions of the special masters will be made available to the public unless they contain trade secrets or commercial or financial information that is privileged and confidential, or medical or similar information whose disclosure would constitute a clearly unwarranted invasion of privacy. When such a decision is filed, petitioner has 14 days to identify and move to delete such information prior to the document’s disclosure. If the special master, upon review, agrees that the identified material fits within the banned categories listed above, the special master shall delete such material from public access. Case 1:14-vv-01111-UNJ Document 33 Filed 12/21/15 Page 2 of 7 The undersigned finds the terms of the stipulation to be reasonable. The court hereby adopts the parties’ said stipulation, attached hereto, and awards compensation in the amount and on the terms set forth therein. Pursuant to the stipulation, the court awards a lump sum of $150,000.00, representing reimbursement for all damages that would be available under 42 U.S.C. § 300aa-15(a) (2012). The award shall be in the form of a check payable to petitioner in the amount of $150,000.00. In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the court is directed to enter judgment herewith.2 IT IS SO ORDERED. Dated: November 30, 2015 s/ Laura D. Millman Laura D. Millman Special Master 2 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party, either separately or jointly, filing a notice renouncing the right to seek review. Case 1:14-vv-01111-UNJ Document 33 Filed 12/21/15 Page 3 of 7 Case 1:14-vv-01111-UNJ Document 33 Filed 12/21/15 Page 4 of 7 Case 1:14-vv-01111-UNJ Document 33 Filed 12/21/15 Page 5 of 7 Case 1:14-vv-01111-UNJ Document 33 Filed 12/21/15 Page 6 of 7 Case 1:14-vv-01111-UNJ Document 33 Filed 12/21/15 Page 7 of 7